iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 751

Identifiers

  • Canonical SMILES:
    CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2Cc1cccnc1)c1c[nH]c2cc(F)ccc12
  • IUPAC name:
    (2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-(pyridin-3-ylmethyl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide
  • InChi:
    InChI=1S/C32H41FN6O2/c1-20(34-2)31(40)37-29(22-8-4-3-5-9-22)32(41)39-14-12-28-30(39)26(19-38(28)18-21-7-6-13-35-16-21)25-17-36-27-15-23(33)10-11-24(25)27/h6-7,10-11,13,15-17,20,22,26,28-30,34,36H,3-5,8-9,12,14,18-19H2,1-2H3,(H,37,40)/t20-,26+,28+,29-,30+/m0/s1
  • InChiKey:
    BDJODIRESHTDBJ-KKQAPILSSA-N

External links


45137640

External search

Bibliography (1)

Publication Name
Stephen M. Condon, Matthew G. Laporte, Tetralogic Pharmaceuticals Corp.. . Iap inhibitors None. 25

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
XIAP / Smac 7.00 cancer Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 560.33 g/mol
HBA 8
HBD 3
HBA + HBD 11
AlogP 2.99
TPSA 93.36
RB 8
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
WO2010033531 25 XIAP
P98170

Biochemical assay Fluorescence Polarization pKd (dissociation constant, -log10) 7.00
Ta Structure Name Drugbank ID
0.7255 (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide DB04724
0.7099 Anamorelin DB06645
0.7040 LTX-315 DB12748
0.6839 TC-6987 DB14854
0.6710 Gramicidin D DB00027
0.6667 Omiganan DB06610
0.6646 Murepavadin DB14777
0.6562 Ilomastat DB02255
0.6524 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID DB08493
0.6524 BQ-123 DB12054
0.6524 Somatoprim DB12777
0.6386 N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE DB08489
0.6329 Macimorelin DB13074
0.6236 Relamorelin DB12678
0.6209 Tifuvirtide DB05413